Nutex Health (NASDAQ:NUTX) Reaches New 1-Year High Following Earnings Beat

Nutex Health Inc. (NASDAQ:NUTX) hit a new 52-week high during trading on Wednesday after the company announced better than expected quarterly earnings. The stock traded as high as $182.00 and last traded at $153.47, with a volume of 256101 shares traded. The stock had previously closed at $125.93.

The company reported $2.56 EPS for the quarter, beating the consensus estimate of ($0.15) by $2.71. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%. The firm had revenue of $211.79 million during the quarter, compared to analysts’ expectations of $81.09 million.

Analyst Upgrades and Downgrades

NUTX has been the subject of several recent research reports. Benchmark increased their price target on Nutex Health from $150.00 to $300.00 and gave the company a “buy” rating in a report on Thursday. Maxim Group raised their target price on Nutex Health from $75.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, April 8th.

Insiders Place Their Bets

In other Nutex Health news, CFO Jon Christian Bates bought 1,000 shares of the business’s stock in a transaction on Tuesday, April 8th. The stock was bought at an average price of $81.81 per share, with a total value of $81,810.00. Following the completion of the purchase, the chief financial officer now directly owns 4,888 shares in the company, valued at $399,887.28. The trade was a 25.72% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 38.52% of the stock is owned by insiders.

Institutional Investors Weigh In On Nutex Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Topline Capital Management LLC purchased a new stake in shares of Nutex Health in the 4th quarter valued at $5,690,000. Essex Investment Management Co. LLC raised its holdings in shares of Nutex Health by 45.4% in the 4th quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company’s stock valued at $3,353,000 after buying an additional 33,024 shares during the period. American Century Companies Inc. raised its holdings in shares of Nutex Health by 73.0% in the 1st quarter. American Century Companies Inc. now owns 74,359 shares of the company’s stock valued at $3,497,000 after buying an additional 31,366 shares during the period. Ancora Advisors LLC purchased a new stake in shares of Nutex Health in the 4th quarter valued at $1,334,000. Finally, Truist Financial Corp raised its holdings in shares of Nutex Health by 22.2% in the 4th quarter. Truist Financial Corp now owns 35,570 shares of the company’s stock valued at $1,127,000 after buying an additional 6,454 shares during the period. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Price Performance

The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36. The stock has a market cap of $960.55 million, a PE ratio of -18.51 and a beta of -0.10. The company has a fifty day moving average of $99.20 and a 200-day moving average of $60.12.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.